勝宏科技(300476.SZ):控股股東持股比例降至20.65%
格隆匯 12 月 31日丨勝宏科技(300476.SZ)公佈,公司收到公司控股股東深圳市勝華欣業投資有限公司(“勝華欣業”)出具的《簡式權益變動報吿書》。2020年4月24日,公司在巨潮資訊網披露了《關於控股股東非公開發行可交換債券換股完成暨換股導致權益變動達到公司股份1%的公吿》,截止當日,勝華欣業可交債持有人已完成全部換股,累計換股2236.32萬股,佔公司總股本的2.87%。同時,因公司股權激勵、非公開發行股票股本、回購註銷部分限制股票導致勝華欣業持有公司股份比例被動發生變化,持股比例合計降低佔公司總股本的7.07%。
此次變動後,勝華欣業持有股份1.61億股,佔變動後總股本比例20.65%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.